|
IMC-11F8 is a fully human IgG1 monoclonal antibody that blocks the ligand binding site of EGFR that is involved in triggering and regulating the malignant growth of many EGFR-expressing epithelial tumors. IMC-11F8 is developed for the treatment of advanced colorectal cancer.
|
